British pharmaceuticals: a cautionary tale

Economy and Society

Volumn 27, Issue 4, 1998, Pages 554-584

  Froud, Julie ^a   Williams, Karel ^a   Haslam, Colin ^b   Johal, Sukhdev ^b   Willis, Robert ^c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF EAST LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPETITIVENESS; INDUSTRIAL POLICY; MANUFACTURING; PHARMACEUTICAL INDUSTRY;

UNITED KINGDOM;

EID: 0032432189     PISSN: 03085147     EISSN: None     Source Type: Journal    
DOI: 10.1080/03085149800000033     Document Type: Article

References (26)

1. _(1990) Patents Working for Patients, London: ABPI.
2. _(1993) Pharma: Facts and Figures, London: ABPI.
3. Blair, T. (1996a) Speech to the Keidanren (Tokyo, 5 January 1996), London: Labour Party.
4. _(1996b) Speech to the Singapore Business Community (Singapore, 8 January 1996), London: Labour Party.
5. BZW (1991) Industry and Perspectives: The World's 50 Best Selling Drugs 1965-89, London: BZW.
6. 2867 (1995) Competitiveness: Forging Ahead, London: HMSO.
7. Danzon, P. M. (1997) Pharmaceutical Price Regulation: National Policies versus Global Interests, Washington, DC: AEI Press.
8. Davis, E., Flanders, S. and Star, J. (1991) 'Assessing corporate performance', Business Strategy Review, 2(2): 1-33.
9. Economist Intelligence Unit (EIU) (1994) The Pharmaceuticals Industry in 2000: Reinventing the Pharmaceutical Company, London: EIU.
10. Financial Times Management Report (1994) Generic Pharmaceuticals: Implications for a Global Pharmaceutical Industry, London: Financial Times.
11. _(1995) Global Pharmaceuticals: Winning Strategies in the Major Manufacturing Markets, Vol. I, London: Financial Times.
12. Hancher, L. (1990) Regulating for Competition: Government, Law and the Pharmaceuticals Industry, Oxford: Clarendon Press.
13. Hart, P. E. (1992) The Effects of '1992' on the Pharmaceuticals Industry in Britain and Germany, Discussion Paper No. 8, London: National Institute for Economic and Social Research.
14. Jordans (1993) The British Pharmaceuticals Industry, Bristol: Jordan & Sons.
15. Kay, J. (1995) Foundations of Corporate Success, Oxford: Oxford University Press.
16. Key Note Market Review (various years) UK Pharmaceutical Industry, London: Key Note.
17. Kitson, M. and Michie, J. (1996) 'Britain's industrial performance since 1960: underinvestment and relative decline', Economic Journal 106(January): 196-212.
18. Krugman, P. (1994) 'Competitiveness: a dangerous obsession', Foreign Affairs March/April: 28-44.
19. Lynn, M. (1991) The Billion Dollar Battle: Merck versus Glaxo, London: Heinemann.
20. Magaziner, I. C. and Reich, R. B. (1982) Minding America's Business: The Decline and Rise of the American Economy, New York: Harcourt Brace.
21. Moran, M. (1995) 'Three faces of the health care state', Journal of Politics, Policy and Law 20(3): 767-81.
22. National Economic Development Council (NEDC Economic Development Committee for Pharmaceuticals) (1986) A New Focus on Pharmaceuticals, London: HMSO.
23. Reich, R. (1991) The Work of Nations, London: Simon & Schuster.
24. Taggart, J. H. (1993) The World Pharmaceutical Industry, London: Routledge.
25. Tyson, L. D'A. (1992) Who's Bashing Whom? Trade Conflict in High Technology Industries, Washington, DC: Institute for Economic Affairs.
26. Waldegrave, W. (1991) 'Speakers' papers', World Pharmaceuticals Conference, 18-19 March, London: Financial Times Conference Organization.